Related Experiment Videos
[Tissue microarrays. High-throughput procedures to verify potential biomarkers].
R Kuefer1, M D Hofer, J E Gschwend
1Urologische Universitätsklinik und Poliklinik Ulm, Universität Ulm. rainer.kuefer@medizin.uni-ulm.de
Der Urologe. Ausg. A
|April 27, 2004
Summary
Tissue microarrays (TMAs) enable rapid verification of potential biomarkers by analyzing hundreds of tissue samples simultaneously. This high-throughput technology accelerates the transition of basic research findings to clinical applications, particularly in prostate cancer.
Area of Science:
- Biomolecular analysis
- Molecular pathology
- High-throughput screening
Context:
- Advancements in high-throughput molecular screening necessitate rapid biomarker verification methods.
- Tissue microarray (TMA) technology offers a solution for efficient protein-level analysis.
- TMAs enable standardized, simultaneous analysis of numerous tissue samples.
Purpose:
- To describe the technical aspects of TMAs as a miniaturized high-throughput technology.
- To demonstrate the utility of TMAs in accelerating biomarker research.
- To highlight the application of TMAs in prostate cancer research.
Summary:
- TMAs involve placing hundreds of small tissue samples (0.6 mm diameter) onto a single glass slide.
- This technique allows for diverse in situ analyses under standardized conditions in a single experiment.
- TMAs are suitable for molecular epidemiology and tumor-specific marker investigations.
Impact:
- TMAs facilitate the efficient analysis of potential biomarkers.
- The technology accelerates the translation of basic research into clinical practice.
- Specifically, TMAs aid in advancing prostate cancer research and clinical applications.